Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2018
Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized TrialsYu-Pei Chen, Ling-Long Tang, Qi Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled TrialAnthony T C Chan, Edwin P Hui, Roger K C Ngan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
NEJM Evidence|February 6, 2024
Plasma Epstein-Barr Virus DNA and Risk of Future Nasopharyngeal CancerK C Allen Chan, W K Jacky Lam, Ann King, et al.
Journal of the National Cancer Institute|April 7, 2005
Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinomaAnthony T C Chan, S F Leung, Roger K C Ngan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2023
Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifsZe Zhou, Mary-Jane L Ma, Rebecca W Y Chan, et al.
Journal of the National Cancer Institute|February 1, 2023
Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regionsW K Jacky Lam, Ann D King, Jacob A Miller, et al.
Pageof 11